US$3,500.00
Aug 2010
Women’s Health Therapeutics, Analysis and Market Forecasts to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in the Menopause and Osteoporosis Markets
GBI Research’s report, “Women's Health Therapeutics Market to 2016 - High Unmet Need will Drive the Uptake of Novel Drugs in Menopause and Osteoporosis”, provides in-depth analysis of unmet needs, drivers and barriers that impact the global women’s health market. The report analyzes the markets for women’s health in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, prices and volumes are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets.
Order Now
|
More Information
|
Tell-a-Friend
US$2,224.00
Jun 2010
Breast Cancer Drugs: World Market Prospects 2010-2025
The breast cancer treatments market generated pharmaceutical revenues of over $11bn worldwide in 2009. The incidence and prevalence of breast cancer have been rising worldwide, in line with ageing populations, lifestyle/environmental factors and improvements in diagnosis. Expanding patient populations worldwide offer significant commercial and therapeutic opportunities, which our new report forecasts and discusses. Governments and other healthcare providers are investing in health education, diagnosis and treatments for this serious - but controllable - disorder.
Order Now |
More Information |
Tell-a-Friend
US$3,400.00
May 2010
Women’s Health Diagnostic Testing
The purpose of this TriMark Publications report is to describe the specific segment of the in vitro diagnostics (IVDs) market called women’s health testing. This study includes contemporary and generally accepted clinical and analytical activities. This analysis examines clinical measurement devices, as well as their reagents and supplies, as utilized in hospitals, clinics and doctor’s offices. Some diagnostic tests, which are marketed primarily as over-the-counter products, are included in this report. This report also includes other important tests like mammography, (i.e., tests which are not generally associated with IVD tests, but which are an important component of the overall women’s health market).
Order Now |
More Information |
Tell-a-Friend
US$3,400.00
May 2010
Mammography World Markets
The women’s mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher interest of individual patients and general healthcare consumers to take charge of their own health status. Continuous improvements in technology are resulting in a growing number of new imaging diagnostic tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. The emphasis in this TriMark Publications report is on those companies and products that are actively developing and marketing clinical laboratory instrumentation and reagents and supplies for performing diagnostic tests on conditions specifically related to women’s health.
Order Now |
More Information |
Tell-a-Friend
US$500.00
Apr 2010
Cyanoacrylates Tissue Adhesives - A Market Snapshot
GlobalData’s report, “Cyanoacrylates Tissue Adhesives: A Market Snapshot” provides key data, information and analysis on the global market for Cyanoacrylate based tissue adhesives used for wound closure and surgical wound closure. The report provides market landscape, procedure numbers and future trend and products information on the Cyanoacrylate tissue adhesives market. The report provides comprehensive information on the key trends affecting the market, and key technology offerings. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.
Order Now |
More Information |
Tell-a-Friend
US$2,000.00
Apr 2010
Polycystic Ovarian Syndrome - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist’s new report, “Polycystic Ovarian Syndrome– Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global polycystic ovarian syndrome market. The report identifies the key trends shaping and driving the global polycystic ovarian syndrome market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global polycystic ovarian syndrome sector.
Order Now |
More Information |
Tell-a-Friend
US$2,000.00
Apr 2010
Women’s Infertility - Drug Pipeline Analysis and Market Forecasts to 2016
GlobalData, the industry analysis specialist’s new report, “Women’s Infertility – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global women’s infertility market. The report identifies the key trends shaping and driving the global women’s Infertility market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global women’s infertility sector.
Order Now |
More Information |
Tell-a-Friend
